Oral Nemonoxacin in Treating Elderly Patients With CAP
Status:
Completed
Trial end date:
2020-03-23
Target enrollment:
Participant gender:
Summary
This study was to evaluate the safety and efficacy of oral nemonoxacin in treating elderly
patients (aged ≥ 65 years) with community-acquired pneumonia (CAP).